1932050-70-8 Usage
Uses
Used in Pesticide Industry:
Tert-butyl (cis-3-hydroxycyclopentyl)methylcarbamate is utilized as an insecticide for its ability to disrupt the neurotransmission in insects, causing paralysis and ultimately leading to their death. tert-butyl (cis-3-hydroxycyclopentyl)methylcarbamate's stability and resistance to degradation make it an effective long-term solution for pest control.
Used in Agricultural Applications:
In agriculture, tert-butyl (cis-3-hydroxycyclopentyl)methylcarbamate serves as a crucial tool for protecting crops from insect damage. Its long-lasting effects ensure a continuous defense against pests, thereby safeguarding the yield and quality of agricultural produce.
Used in Public Health:
Tert-butyl (cis-3-hydroxycyclopentyl)methylcarbamate is also employed in public health initiatives to control insect-borne diseases. By targeting the insects that transmit pathogens, tert-butyl (cis-3-hydroxycyclopentyl)methylcarbamate helps in reducing the spread of diseases and improving overall public health.
However, it is essential to handle tert-butyl (cis-3-hydroxycyclopentyl)methylcarbamate with care due to its potential toxicity to humans and other non-target organisms. Proper application and safety measures are crucial to ensure its effectiveness while minimizing risks to the environment and human health.
Check Digit Verification of cas no
The CAS Registry Mumber 1932050-70-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,9,3,2,0,5 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1932050-70:
(9*1)+(8*9)+(7*3)+(6*2)+(5*0)+(4*5)+(3*0)+(2*7)+(1*0)=148
148 % 10 = 8
So 1932050-70-8 is a valid CAS Registry Number.
1932050-70-8Relevant academic research and scientific papers
NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
-
, (2014/07/07)
A compound of formula (I), wherein: M is hydrogen or a pharmaceutically acceptable salt-forming cation; Y is OR1 or NR2R3, and R1,R2, R3 and M are as defined herein. Also, methods of treating bacterial infection, pharmaceutical compositions, molecular complexes and processes for preparing compounds.
NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS
-
, (2013/09/12)
A compound of formula (I): wherein: M is hydrogen or a pharmaceutically acceptable salt-forming cation; Y is OR1 or NR2R3, and R1, R2, R3 and M are as defined herein. Also, methods of treating bacterial infection, pharmaceutical compositions, molecular complexes and processes for preparing compounds.
